US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, The United States Government as represented by the Department of Veterans Affairs on Sept. 8 for "Growth and differentiation factor 15 for treatment of proliferative vitreoretinopathy therapy" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,152, issued on Sept. 8, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.) and The United States Government as represented by the Department of Veterans Affairs (Washington).

"Growth and differentiation factor 15 for treatment of proliferative vitreoretinopathy therapy" was invented by Jeffrey Louis Goldberg (Menlo Park, Calif.) and Kun-Che Chang (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An effective dose of Growth Differentiation Factor 15 (GDF15) is used for prevention or treatment of proliferative vitreoretinopathy. Specifically, the disclosure provides methods and composit...